Literature DB >> 11788825

Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin.

Xiaolei Xu1, Steffen E Meiler, Tao P Zhong, Manzoor Mohideen, Dane A Crossley, Warren W Burggren, Mark C Fishman.   

Abstract

The zebrafish embryo is transparent and can tolerate absence of blood flow because its oxygen is delivered by diffusion rather than by the cardiovascular system. It is therefore possible to attribute cardiac failure directly to particular genes by ruling out the possibility that it is due to a secondary effect of hypoxia. We focus here on pickwickm171 (pikm171), a recessive lethal mutation discovered in a large-scale genetic screen. There are three other alleles in the pik complementation group with this phenotype (pikm242, pikm740, pikm186; ref. 3) and one allele (pikmVO62H) with additional skeletal paralysis. The pik heart develops normally but is poorly contractile from the first beat. Aside from the edema that inevitably accompanies cardiac dysfunction, development is normal during the first three days. We show by positional cloning that the 'causative' mutation is in an alternatively-spliced exon of the gene (ttn) encoding Titin. Titin is the biggest known protein and spans the half-sarcomere from Z-disc to M-line in heart and skeletal muscle. It has been proposed to provide a scaffold for the assembly of thick and thin filaments and to provide elastic recoil engendered by stretch during diastole. We found that nascent myofibrils form in pik mutants, but normal sarcomeres are absent. Mutant cells transplanted to wildtype hearts remain thin and bulge outwards as individual cell aneurysms without affecting nearby wildtype cardiomyocytes, indicating that the contractile deficiency is cell-autonomous. Absence of Titin function thus results in blockage of sarcomere assembly and causes a functional disorder resembling human dilated cardiomyopathies, one form of which is described in another paper in this issue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788825     DOI: 10.1038/ng816

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  94 in total

Review 1.  M-band: a safeguard for sarcomere stability?

Authors:  Irina Agarkova; Elisabeth Ehler; Stephan Lange; Roman Schoenauer; Jean-Claude Perriard
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

2.  High-resolution cardiovascular function confirms functional orthology of myocardial contractility pathways in zebrafish.

Authors:  Jordan T Shin; Eugene V Pomerantsev; John D Mably; Calum A MacRae
Journal:  Physiol Genomics       Date:  2010-04-13       Impact factor: 3.107

3.  Zebrafish as a model for cardiovascular development and disease.

Authors:  Catherine T Nguyen; Qing Lu; Yibin Wang; Jau-Nian Chen
Journal:  Drug Discov Today Dis Models       Date:  2008

4.  The zebrafish runzel muscular dystrophy is linked to the titin gene.

Authors:  Leta S Steffen; Jeffrey R Guyon; Emily D Vogel; Melanie H Howell; Yi Zhou; Gerhard J Weber; Leonard I Zon; Louis M Kunkel
Journal:  Dev Biol       Date:  2007-06-23       Impact factor: 3.582

5.  Depletion of zebrafish titin reduces cardiac contractility by disrupting the assembly of Z-discs and A-bands.

Authors:  Michael Seeley; Wei Huang; Zhenyue Chen; William Oscar Wolff; Xueying Lin; Xiaolei Xu
Journal:  Circ Res       Date:  2006-12-14       Impact factor: 17.367

Review 6.  Titin/connectin-related proteins in C. elegans: a review and new findings.

Authors:  Tracey M Ferrara; Denise B Flaherty; Guy M Benian
Journal:  J Muscle Res Cell Motil       Date:  2005       Impact factor: 2.698

Review 7.  Illuminating cardiac development: Advances in imaging add new dimensions to the utility of zebrafish genetics.

Authors:  Jeffrey J Schoenebeck; Deborah Yelon
Journal:  Semin Cell Dev Biol       Date:  2006-12-27       Impact factor: 7.727

8.  Vertebrate heart growth is regulated by functional antagonism between Gridlock and Gata5.

Authors:  Haibo Jia; Isabelle N King; Sameer S Chopra; Haiyan Wan; Terri T Ni; Charlie Jiang; Xiaoqun Guan; Sam Wells; Deepak Srivastava; Tao P Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

Review 9.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

Review 10.  Target of rapamycin (TOR)-based therapy for cardiomyopathy: evidence from zebrafish and human studies.

Authors:  Sudhir Kushwaha; Xiaolei Xu
Journal:  Trends Cardiovasc Med       Date:  2012-07-28       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.